Inovexus Early Stage Fund Master Entity, LP - B2 is a venture capital fund based in Seattle, Washington. According to its most recent Form D, filed Jun 13, 2023, it has sold $195,202 of interests to 17 investors since its first sale in Apr 2023. The minimum investment it accepts from an outside investor is $6,240. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(c), which permits general advertising to investors verified as accredited. Related persons named in the filing include Ltd. Belltower Fund Group; LLC Fund GP.
- Total raised
- $195,202Cumulative sales reported on Form D
- Investors
- 17
- First sale
- Apr 18, 2023
- Minimum investment
- $6,240
- Who can invest
- Accredited investorsSection 3(c)(1): up to 100 beneficial owners
- Offering exemption
- Rule 506(c)May advertise; investors must be verified as accredited
- Key people and entities
- Ltd. Belltower Fund Group; LLC Fund GP
- Latest Form D
- Jun 13, 2023
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Raise history
| Filed | Filing | Total raised | Investors | Source |
|---|---|---|---|---|
| Jun 13, 2023 | Form D/A (amendment) | $195,202 | 17 | SEC.gov ↗ |
| Jun 2, 2023 | Form D | $94,990 | 8 | SEC.gov ↗ |
2 Form D filings in the SEC's electronic records (2008 onward), the earliest on Jun 2, 2023. Each filing reports the cumulative amount sold and the number of investors to that date, as the fund filed it. Not verified, and not the fund's current assets. Source: U.S. Securities and Exchange Commission, Form D data sets.
Related vehicles with the same name (7)
| Vehicle | Total raised | Investors | Latest Form D |
|---|---|---|---|
| Inovexus Early Stage Fund Master Entity, LP - B2 (this page) | $195,202 | 17 | Jun 13, 2023 |
| Inovexus Early Stage Fund Master Entity, LP - B1 | $142,500 | 11 | Jan 11, 2023 |
| Inovexus Early Stage Fund Master Entity, LP - A3 | $137,495 | 12 | Jul 13, 2022 |
| Inovexus Early Stage Fund Master Entity, LP - A4 | $131,220 | 12 | Oct 7, 2022 |
| Inovexus Early Stage Fund Master Entity, LP - B3 | $89,753 | 17 | Mar 20, 2024 |
| Inovexus Early Stage Fund Master Entity, LP - A1 | $25,000 | 4 | Jan 26, 2022 |
| Inovexus Early Stage Fund Master Entity, LP - A2 | $25,000 | 1 | Apr 18, 2022 |
Funds are often offered through several legal vehicles, such as onshore, offshore, feeder, parallel or tax-exempt versions, and each one files its own Form D. These 7 filings share this fund's name apart from such vehicle words or a series letter, which usually means they are versions of one fund. Grouped by AltMountain from the names on the filings alone, so the list may be incomplete or include a separate fund with a near-identical name; amounts are each vehicle's own filing and should not be added together, because a feeder's money can also be counted in its master fund. Source: SEC Form D filings.
Questions about Inovexus Early Stage Fund Master Entity, LP - B2
What is the minimum investment for Inovexus Early Stage Fund Master Entity, LP - B2?
According to its latest Form D, filed Jun 13, 2023, the minimum investment Inovexus Early Stage Fund Master Entity, LP - B2 accepts from an outside investor is $6,240.
Who can invest in Inovexus Early Stage Fund Master Entity, LP - B2?
Inovexus Early Stage Fund Master Entity, LP - B2 is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(c), so it may advertise, but every investor must be verified as accredited.
How much has Inovexus Early Stage Fund Master Entity, LP - B2 raised?
Inovexus Early Stage Fund Master Entity, LP - B2 reports $195,202 sold from 17 investors on its Form D filed Jun 13, 2023. This is cumulative sales since the offering began, not current assets or performance.
Where is Inovexus Early Stage Fund Master Entity, LP - B2 based?
Inovexus Early Stage Fund Master Entity, LP - B2 is based in Seattle, Washington.
When did Inovexus Early Stage Fund Master Entity, LP - B2 launch?
Inovexus Early Stage Fund Master Entity, LP - B2 reports its first sale in Apr 2023.
Size compared with every venture capital fund
Raised more than 47% of the 5,438 venture capital funds based in Washington, and more than 29% of all 14,901 that report sales.